EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Edesa Biotech, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.78+0.21 (+8.17%)
Close on Oct 19, 2026
- Market cap
- $25.04M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Edesa Biotech from other investors
No posts about EDSA yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.